A detailed history of Advisor Group Holdings, Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 732 shares of BVS stock, worth $5,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
732
Previous 38,804 98.11%
Holding current value
$5,380
Previous $256,000 98.44%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$6.14 - $7.64 $233,762 - $290,870
-38,072 Reduced 98.11%
732 $4,000
Q2 2025

Sep 04, 2025

BUY
$6.2 - $9.51 $3,813 - $5,848
615 Added 1.61%
38,804 $256,000
Q2 2025

Aug 13, 2025

SELL
$6.2 - $9.51 $6,423 - $9,852
-1,036 Reduced 2.64%
38,189 $252,000
Q1 2025

May 12, 2025

BUY
$8.76 - $11.05 $3,285 - $4,143
375 Added 0.97%
39,225 $358,000
Q4 2024

Jun 06, 2025

SELL
$10.5 - $13.71 $6,457 - $8,431
-615 Reduced 1.57%
38,610 $405,000
Q2 2024

Aug 13, 2024

BUY
$3.96 - $6.93 $2,178 - $3,811
550 Added 1.44%
38,850 $223,000
Q1 2024

May 10, 2024

BUY
$4.33 - $5.75 $1,299 - $1,725
300 Added 0.79%
38,300 $199,000
Q3 2023

Nov 13, 2023

SELL
$2.8 - $4.94 $109,200 - $192,660
-39,000 Reduced 50.65%
38,000 $125,000
Q2 2023

Aug 10, 2023

BUY
$0.93 - $3.64 $71,610 - $280,280
77,000 New
77,000 $222,000
Q4 2022

Feb 10, 2023

SELL
$1.81 - $8.14 $8,751 - $39,356
-4,835 Reduced 81.81%
1,075 $2,000
Q3 2022

Nov 14, 2022

BUY
$6.54 - $9.08 $1,883 - $2,615
288 Added 5.12%
5,910 $41,000
Q2 2022

Aug 10, 2022

BUY
$6.82 - $13.82 $27,089 - $54,893
3,972 Added 240.73%
5,622 $38,000
Q1 2022

May 04, 2022

SELL
$11.65 - $15.28 $687 - $901
-59 Reduced 3.45%
1,650 $23,000
Q3 2021

Nov 05, 2021

BUY
$13.7 - $17.25 $20,673 - $26,030
1,509 Added 754.5%
1,709 $24,000
Q1 2021

May 13, 2021

BUY
$11.49 - $19.21 $2,298 - $3,842
200 New
200 $3,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $453M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.